Human endotoxemia as a model of systemic inflammation

Area of Science:

• Immunology
• Pathophysiology
• Human experimental models

Background:

• Systemic inflammation is a key factor in numerous acute and chronic diseases, including sepsis, type 2 diabetes, atherosclerosis, and Alzheimer's disease.
• Despite its prevalence, the molecular mechanisms and physiological roles of systemic inflammation remain incompletely understood.
• The human endotoxin model provides a controlled in vivo approach to investigate systemic inflammation.

Purpose of the Study:

• To review the fundamental changes observed in the human endotoxin model.
• To describe inflammatory cascade activation and organ-specific responses to lipopolysaccharide (LPS).
• To discuss the limitations and ethical considerations of using this model in research.

Main Methods:

• Intravenous injection or infusion of lipopolysaccharide (LPS) into healthy human volunteers.
• Observation and analysis of systemic inflammatory responses.
• Assessment of organ-specific hemodynamic and functional alterations.

Main Results:

• Activation of key inflammatory cascades following LPS administration.
• Demonstration of distinct organ-specific hemodynamic and functional changes.
• Identification of limitations in translating findings from experimental models to clinical disease.

Conclusions:

• The human endotoxin model is a valuable tool for studying the pathophysiology of systemic inflammation.
• Understanding LPS-induced changes offers insights into diseases characterized by inflammation.
• Careful consideration of model limitations and ethical aspects is crucial for accurate interpretation and application of results.